Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06255_nanopub.RASgxLraJmbPl8F56oFW2Q21Lt4G565V385mgiNyTiANI#assertion>. }
Showing items 1 to 14 of
14
with 100 items per page.
- drugbank:DB06255 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06255 label "Incadronate [drugbank:DB06255]" assertion.
- drugbank:DB06255 seeAlso DB06255 assertion.
- drugbank:DB06255 description "Incadronic acid is a third generation bisphosphonate which can suppress bone resorption by osteoclasts. It is used to treat hypercalcemia, and bone disorders associated with malignancy and osteoporosis. In rats with induced hypercalcemia, incadronate has been found to be 46 times more potent than pamidronate and 11 times more potent than aledronate. Incadronate has also been found to have anti-tumor effects in mice. In rat models of breast cancer, bisphosphonate treatment has been shown to inhibit the progression and development of bone metastases and reduce tumor burden in vivo. It has also been recognized as a potential treatment for adult T-cell leukaemia which is characterized by hypercalcemia and tumor-induced osteolysis. [4] Incadronate, as well as other nitrogen containing bisphosphonates, such as aledronate and minodronate, have been found to induce apoptosis of hematopoietic tumor cells. In vitro human myeloma cells have undergone apoptosis when exposed to incadronate. [7] When combined with Tipifarnib, a potent farnesyl transferase inhibitor which can suppress the growth of myeloma cells, growth suppression of myeloma cells in vitro is intensified. [6] Because of these findings Incadronate is being investigated as a treatment for multiple myeloma, a B-cell malignancy associated with bone loss. Incadronate is available by prescription only, and is not marked is the United States, UK, Canada, or Australia. [Wikipedia] It is an approved treatment for malignancy-associated hypercalcemia (MAH) in Japan.[3]" assertion.
- drugbank:DB06255 identifier "drugbank:DB06255" assertion.
- drugbank:DB06255 title "Incadronate" assertion.
- drugbank:DB06255 drugbank_vocabulary:x-cas cas:138330-18-4 assertion.
- drugbank:DB06255 drugbank_vocabulary:drugbank-id "DB06255" assertion.
- drugbank:DB06255 bio2rdf_vocabulary:x-identifiers.org DB06255 assertion.
- drugbank:DB06255 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06255" assertion.
- drugbank:DB06255 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06255 bio2rdf_vocabulary:identifier "DB06255" assertion.
- drugbank:DB06255 drugbank_vocabulary:x-wikipedia wikipedia:Incadronic_acid assertion.
- drugbank:DB06255 drugbank_vocabulary:x-kegg kegg:D07123 assertion.